Compass Therapeutics (CMPX) Revenue & Revenue Breakdown
Compass Therapeutics Revenue Highlights
00
Compass Therapeutics Revenue by Period
Compass Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-03-31 | - | - |
Compass Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Compass Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | -100.00% |
2024-06-30 | $850.00K | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $2.84M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | - |
Compass Therapeutics generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Compass Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TRDA | Entrada Therapeutics | $210.78M | $37.40M |
HOWL | Werewolf Therapeutics | $1.89M | - |
CRNX | Crinetics Pharmaceuticals | $1.04M | - |
IKNA | Ikena Oncology | - | - |
CMPX | Compass Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
ANNX | Annexon | - | - |
JBIO | Jade Biosciences | - | - |
IRON | Disc Medicine | - | - |
CNTA | Centessa Pharmaceuticals | - | - |
LRMR | Larimar Therapeutics | - | - |